Augmedix, a San Francisco, CA-headquartered, smartglass-based physician productivity platform, closed a $23m strategic round of funding.
Backers included new investors McKesson Ventures and OrbiMed and existing investors Redmile Group, Emergence Capital and DCM Ventures.
The company, which has received more than $60 million in venture funding since founding, intends to use the funds to further scale its service nationwide and build out its platform with new tools and services.
Founded in 2012, Augmedix provides a Google Glass-powered remote scribe service that reduce doctors’ time dedicated to mandated charting and documentation.
Using Augmedix and Google Glass, physicians retrieve patient medical history and document the patient visit without having to interact with a computer. The chart note is created in real time by remote scribes based in secure HIPAA-compliant facilities. The physician is then able to review the note and a summary of the visit can be provided to the patient with care instructions.
The remote scribe service is complemented by additional enterprise support services, assisting health systems with staffing, quality assurance, network and technical support, analytics and business process improvement.